801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsOral Medications

Pentoxifylline tablets 400mg Modified-release 400mg Oral Medications

Pentoxifylline tablets 400mg Modified-release 400mg Oral Medications

Pentoxifylline tablets 400mg Modified-release 400mg Oral Medications

Product Details:

Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 400mg

Payment & Shipping Terms:

Minimum Order Quantity: one million tablets
Price: Negotiation
Packaging Details: 10’s/box
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: One million pills per day
Contact Now
Detailed Product Description
Product: Pentoxifylline Tablets 400mg Modified-release Specification: 400mg
Standard: BP, USP Packing: 10’s/box

Pentoxifylline tablets 400mg Modified-release 400mg Oral Medications

 

Product : Pentoxifylline tablets 400mg Modified-release

Specification : 400mg

Standard : BP, USP

Packing : 10’s/box

 

Description :

A methylxanthine derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.

 

Indication

For the treatment of patients with intermittent lameness or immobility arising from chronic occlusive arterial disease of the limbs.

 

Pharmacodynamics

Pentoxifylline, a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine, is used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

 

Mechanism of action

Pentoxifylline inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, pentoxifylline also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity. It is also a non selective adenosine receptor antagonist.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Luke Liu

Send your inquiry directly to us (0 / 3000)